Vtesse Overview

  • Founded
  • 2014

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $200M

Vtesse General Information

Description

Developer of new drug treatments designed to treat severe and life-threatening diseases. The company's new drug treatments, includes treatment for rare disease Niemann-Pick Disease Type C (NPC), enabling patients with NPC and other lysosomal storage diseases to get treated. It also offers information, resources and support that can be used to better understand NPC and to cope with its impact on lives.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Information Services (B2C)
Biotechnology
Primary Office
  • 910 Clopper Road
  • Suite 220 South
  • Gaithersburg, MD 20878
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vtesse Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 03-Apr-2017 $200M 0000 00000 Completed Startup
2. Early Stage VC (Series A) 25-Jul-2016 0000 0000 000.00 Completed Clinical Trials - Phase 2
1. Accelerator/Incubator Completed Clinical Trials - Phase 2
To view Vtesse’s complete valuation and funding history, request access »

Vtesse Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00 00 00 00 00.000
To view Vtesse’s complete cap table history, request access »

Vtesse Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of new drug treatments designed to treat severe and life-threatening diseases. The company's new drug treatmen
Drug Discovery
Gaithersburg, MD
10 As of 2017
0000
0000 0000-00-00
000000&0 0000

000000

ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000 000000000
South San Francisco, CA
00 As of 0000
000.00
00000000000 000.00

000000

ip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum do
0000 000000000
San Carlos, CA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vtesse Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurona Therapeutics Venture Capital-Backed South San Francisco, CA 00 000.00 00000000000 000.00
0000000 Venture Capital-Backed San Carlos, CA 00 000.00 00000000000 000.00
000000000 Venture Capital-Backed San Carlos, CA 00 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Cambridge, MA 000 00000 00000000000 00000
00000 000000000000 Venture Capital-Backed Woburn, MA 00 00000 00000000000 00000
You’re viewing 5 of 18 competitors. Get the full list »

Vtesse Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vtesse Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Bay City Capital Venture Capital Minority 000 0000 000000 0
Cydan Accelerator/Incubator Minority 000 0000 000000 0
Lundbeckfond Ventures Corporate Venture Capital Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »